Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Recursion Pharmaceuticals (RXRX) closed the last trading session at $8.59, gaining 20% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set ...
That brings us to Recursion Pharmaceuticals (RXRX 3.21%), a biotech company specializing in drug discovery using artificial intelligence (AI). At least one notable name in the investing world thinks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results